PANSS, The Positive and Negative Syndrome Scale
Use of these drugs peaks in middle age, then falls off a cliff right at 65
49 Babenko AY, Savitskaya DA, Kononova YA, Trofimova AY, Simanenkova AV, Vasilyeva EY, et al
By integrating genomics, transcriptomics, and proteomics analyses of G6PD-associated disorders, a novel area of G6PD research may be explored
[2] This dual action helps to regulate blood glucose levels without causing significant hypoglycaemia when used as monotherapy, though the risk increases when combined with insulin or sulfonylureas
Data demonstrated improvements in the metabolic profile of diet-induced obese (DIO) mice treated with Vikings compounds as compared to control cohorts